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no evidence for the preferential usage of particular Vp-families in 
eight patients with MF or NNHL. Finally, the authors discussed the 
value of their experimental design for the differentiation of malig-
nant from non-malignant T-cell proliferations, for the staging of 
malignant lymphomas, and for possible therapeutic approaches 
with monoclonal antibodies. 
Indeed, the semiquantitative analysis of T-cell receptor gene re-
arrangements can be a powerful tool for the investigation of malig-
nant and non-malignant T-cell proliferations but, in our opinion, 
there are some technical pitfalls that have to be considered. 
It is impossible to infer from the fact that there was amplification 
with all 20 Vp primer sets in healthy volunteers that the amplifica-
tion products were actuall y specific V p genes. It is also impossible to 
exclude cross reactivity between the 20 primer sets by examination 
of on ly three cell lines. 
One major problem for primer design within a multigene family 
is the variable level of homology between family members. This 
makes it difficult to design primers that are both sensitive and spe-
cific for all members of a given family. For example, the primers for 
Vp 8 as presented by Preesman and colleagues match to the Vp 
8.1- 8.4 genes, but not to Vp 8.5 and 8.6. The Vp 7 primers match 
only to the family member Vp7.1. The primers VP"12b" and "13" 
both match to the clone pi 4.24 (as described by Concannon et al [7]) 
and are therefore nonspecific. For this reason, other groups working 
in th is area have proved the specificity of their amplification by 
Southern blotting, oligomer extension reactions, or DNA sequenc-
ing [3-5] . 
An important determinant of the accuracy of semiquantitative 
PCR experiments is an equal amplification efficiency between the 
different primers . The melting temperatures of the PCR primers are 
important in this respect and should be grouped within a narrow 
range. The C p primer used by Preesman el al has a melting temper-
ature of77.2 °C, whereas the Vp 1 primer melts at 54.7"C (calcu-
lated accordin g to the nearest neighbor method [9]) . This mismatch 
of melting temperatures complicates the quantitative interpretation 
of the PCR results. To improve precision and accuracy, several 
other investigators [3 - 5] have coamplified a control TCR constant 
region segment as well as a unique ~CR Vp seg~ent in each reac-
tion tube. The coamplified segment III each tube IS used as a control 
for reaction variation and to determine the proportion of the respec-
tive Vp signal within the T-cell message pool. 
Another factor complicating Vp gene family semiquantitative 
analysis is the fact that the V{J families include varying numbers of 
members (e.g., Vp 1 has two members and Vp 6 has at least nine 
[10]) . Therefore, it is impossible to ~etermi~le the pr~va l en~e of 
specific V p fami ly utilization by visual IIlSpectlon of the 111tenSIty of 
a band ofPCR products. For example, if the usage ofV~ genes ill the 
general population is random, the signal for V{J 6 will always be 
more intense than the signal for Vp 1. 
The semiquantitative analysis of a multigene family such as 
TCR-VP by PCR is a challenging technical problem. It requires 
careful evaluation and optimization of several different amplifica-
tion conditions that influence the outcome of these experiments. 
Especially in cases of probable low tumor-cell density, such as earl y 
MF lesions, the above-mentioned technical problems complicate 
quantitative conclusions concerning tumor cell preva lence. Conse-
quently, it is difficult to use semiquantitative analysis of V{J gene 
family PCR products to detect malignant clones that constitute only 
a small proportion of aT-cell population. T his point has been made 
previously by Bahler et al [11] who showed that, when diluted by 
polyclonal T cel ls, a malignant T-cell clone must constitute at least 
- 10% of the total T -cell RNA or DNA to be detectable using a Vp 
gene family PCR assay. Therefore, such assays should be used 
cautiously to detect monoclonality in cases of possible low tumor-
cell density because of the increased risk of false negative resu lts as 
tumor-cell density decreases. 
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REPLY 
Our primer set to detect the different T-cell receptor (TC R) V{J 
gene families revealed highly reproducible results ll -3]. We also 
employed hybridization with an internal J{J-oligonucleotide probe 
on dried gels to obtain positive identification of the PCR products 
[1] . The bands observed coincide with those of ethidiumbromide 
sta ined gel [1] . T here was a very good correlation between the actual 
and calculated size of the PCR products (Hu, unpublished data). We 
also applied, for specificity reasons, sequencing of our PCR products 
in present experiments. So far we have not found discordant find-
ings between PCR V {J ana lysis and sequencing data [4] . For accurate 
specificity these investigations should be performed; therefore we 
ca n agree with Haffner et af on this point. However, the experi-
ments described were carried out in 1991 and indeed this fi eld 
progresses fast. 
We agree, as stated earlier [3 J, that the primer set does not cover 
all V{J gene fami lies or V{J gene fami ly members. On the other hand, 
however, we were able to detect the V {J gene usage in the four cases 
of primary nodal non-Hodgkin'S lymphoma (NHL) and the three 
patients with tumor-stage mycos is fungoides (MF) , which was the 
main interest of our study. So, despite the improvement of tech-
nique at present the conclusions still stand. Furthermore, we added 
four extra Vp oligonucleotides after this study, to incorporate more 
V{J families [4] . 
Extensive experiments were carried out to eva luate the optimal 
PCR conditions. The conditions of the method were chosen in such 
a way that all 20 V{J gene families could be assessed , irrespective of 
the dependency of PCR condi tions like nucleotide composition of 
the primers and the size of the fragment to be amplified [1] . T he use 
of the same conditions ofpCR amplification of each Vp gene fami ly 
may affect the detection of V{JI0 and V{J19. Generally the signal 
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after PCR amplification for these families was rather low, irrespec-
tive of the PCR conditions [1,3]. A low level of expression for these 
V{J families in healthy volunteers was also reported by Robinson [5] . 
In our hands, theoretically determined melting temperatures often 
do not correlate with optimal PCR conditions. As stated earlier 
[1 ,3J, our approach is not suitable for absolute quantitative analysis. 
But as all families are amplified under the same conditions in the 
same experiment, semiquantitative results can be obtained, by com-
paring the signal intensities. 
The authors state that PCR products ofV{J gene families consist-
ing of a relatively large number of members, for instance Vp 6, will 
always reveal more intense signals in the gels compared with V{J 
genes composed of a small number of members, for instance V{J1. 
Recently evidence was put forward that the usage ofVP gene seg-
ments is not proportional to the gene number [5]. This is also con-
firmed by our experiments [1,3]; therefore we can not agree on this 
statement. 
We confirm, as stated eariier [3], that especially in samples with a 
low tumor-cell density the method used by our group is not suitable 
to detect the malignant T-cell population. This was not the focus of 
this paper, because we wished to study the Vp-gene family usage in 
these malignancies and to investigate whether there was a restricted 
V{J family usage in T -cell malignancies, as was suggested by others 
[6]. Our data indicated that indeed one or two V {J gene families were 
selected, without a preferential V p gene family usage in either of the 
patients with mycosis fungoides or in the cases with nodal T-cell 
NHL. 
BOOK REVIEW 
A Practical Gu'ide to Human Cancer Genetics. By S. V. Hodg-
son and E. R. Maher, Cambridge University Press, Cambridge, 
1993 (240 pp, S83). 
This slim volume is designed to be a concise reference to cancer 
genetics for both the clinician and the basic scientist. The book is 
organized into 5 parts. A short (22-page) review of general princi-
ples of cancer genetics, and a 16-page appendix covering fundamen-
tals of molecular biology and mechanisms of inheritance surround 
the meat of the book: genetics of human cancers by site of origin and 
inherited cancer predisposition syndromes (in alphabetical order). 
The final section contains more than 800 references from Ab-
bassioun, K. to Zwetsloot, C. P. There is a 12-page index. 
The descriptions of cancers by organ site and syndrome include 
clinical features, mention of associated syndromes, and a summary 
of reported chromosomal and molecular abnormalities. There fre-
quently are comments about methods of following patients for 
cancer detection or prevention and availability of prenatal diagnosis. 
Most are authoritative, concise, and readable. 
Although covering cancer genetics in general, the authors detail 
more than 50 disorders with dermatologic components. There is a 
very useful table listing many inherited disorders associated with 
skin neoplasms. (U nfortunately the tables are not listed separately in 
the Table of Contents and are thus hard to find.) The disorders 
range from the common (e.g., albinism) to the extremely rare: 
Rombo syndrome (follicular atrophy of the cheeks in childhood and 
basal cell carcinoma in the third decade in a four-generation family) . 
There are nice descriptions of neurofibromatosis, tuberous sclerosis, 
and xeroderma pigmentosum (inexplicably spelled two different 
ways in the same section). 
The organization of the skin disorders appears to be rather arbi-
trary: "inherited conditions predisposing to dermatologic malig-
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nancy" include epidermodysplasia verruciformis whereas dysplastic 
nevus syndrome is in "skin tumors and inherited disorders predis-
posing to skin tumors" but xeroderma pigmentosum is in "inherited 
cancer predisposing syndrome." The best approach for the reader is 
to refer to the Table of Contents, which is generally in alphabetical 
order and thus also serves as an index of disorders. 
Unfortunately the coverage is variable: for example, there are 
only five lines of text on epidermodysplasia verruciformis and the 
only references to human papilloma virus typing date to 1979. Pro-
teus syndrome is described without noting the similarity to neurofi-
bromatosis. Indeed the famed "elephant man" probably had Proteus 
syndrome rather than von Recklinghausen disease. The failure to 
explain acronyms is rather annoying: NAME syndrome is also 
called LAMB syndrome but neither acronym is decoded. 
J found the sections on principles of genetics (part 1) and the 
appendix on fundamentals of genetics to be real gems. They cover 
important principles concisely and provide many useful tables. 
There is a good description of types of chromosomal defects and 
nomenclature plus a sophisticated discussion of sing le gene defects 
including difference between expression and penetrance of domi-
nant disorders, gonadal mosaicism, X-linked dominant inherited 
disorders, mitochondrial mutations, and genomic imprinting. They 
discuss topics as basic as molecular mechanisms of carcinogenesis 
and those as practical as ethical issues in human cancer genetics. 
I found this book to be a useful, though variable, concise com.pen-
dium of clinical cancer genetic disorders with valuable reviews of 
the scientific foundations of human genetics. 
Kenneth Kraemer 
Bethesda, Maryland 
